Across North America, the peptide therapeutics segment is expanding steadily, supported by strong healthcare infrastructure, rising healthcare expenditure, and increasing focus on precision medicine. The region benefits from the presence of leading pharmaceutical companies, advanced research institutions, and a well-established clinical trial network that supports continuous innovation in...